News | News By Subject | News by Disease News By Date | Search News

Anemia, sickle cell News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Global Blood Therapeutics (GBT) Stock Surges on Promising Sickle Cell Drug Results     6/10/2016
bluebird bio (BLUE) Gets Banged Up on Report of Gene Therapy Patient Needing Blood Transfusions     10/21/2015
Novartis AG (NVS) Takes Another 2.5% Stake in Gamida Cell     10/12/2015
bluebird bio (BLUE) Surges as Pioneering Sickle Cell Gene Therapy Working for 13-Year-Old French Boy     6/18/2015
Stock Soars as bluebird bio (BLUE) Gives Sneak Peek at Promising Sickle Cell Data     5/26/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
J.P. Morgan: bluebird bio (BLUE) Soars On CEO's Sickle Cell Data     1/16/2015
bluebird bio (BLUE)’s New Blood Treatment Could Benefit Sickle Cell, Says Analyst     12/9/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
LentiGlobin Looks Promising On Sickle Cell For bluebird bio (BLUE), Says Analyst     11/19/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Cellerant Therapeutics, Inc. Raises $16 Million To Advance Stem Cell-Based Therapies For Life-Threatening Diseases; Series B proceeds To Fund Cancer, Sickle Cell And Autoimmune Programs     5/11/2005
National Institutes of Health (NIH) Issues Alert; Federal Health Agency Halts Sickle Cell Study Because Subjects Suffer Strokes     12/6/2004
Icagen, Inc. Receives Milestone Payment From McNeil Consumer & Specialty Pharmaceuticals (JNJ)     9/2/2004

News from Around the Web
Stanford University Researchers Use CRISPR to Repair Gene That Cause Sickle Cell, Human Trials Planned     11/8/2016
An Easy Test for Sickle Cell Disease, University of Connecticut Study     11/5/2015
Stem Cell Transplant Stops Sickle Cell In Potential Cure, National Institutes of Health (NIH) Reveals     7/2/2014
Malaria May Be Eliminated From a Quarter of Nations in 10 Years, Roll Back Malaria Partnership Reveals     10/18/2011
Fetal Hemoglobin Production Reverses Sickle Cell Anemia, Dana-Farber Cancer Institute Study     10/14/2011
Common Drug Helps Babies with Sickle Cell Disease, St. Jude Children's Research Hospital Study Finds     5/13/2011
American Society of Hematology: Compound Cuts Death Risk for Sickle Cell Kids     12/6/2010
Inhaling Nitric Oxide Eases Pain Crises in Sickle Cell Patients, Medical College of Georgia Researchers Find     10/20/2010
National Heart, Lung, and Blood Institute Stops Study of Treatment for Pulmonary Hypertension in Patients with Sickle Cell Disease Due to Safety Concerns     7/28/2009
Gene May Open Door For New Sickle Cell Therapies, Harvard Medical School Study     12/5/2008
Researchers At Johns Hopkins University Develop Stem Line With Sickle Cell Mutation     5/30/2008
Scientists Cure Mice With Sickle Cell     12/7/2007
Anticancer Drugs Might be of Benefit to Sickle-Cell Patients     12/7/2007
Blood Test Predicts Sickle Cell Disease Complication, Identifies Patients At High Risk Of Death     7/19/2006
Anomalous Renal Effects Of Tin Protoporphyrin In A Murine Model Of Sickle Cell Disease     7/19/2006

Press Releases
Global Blood Therapeutics (GBT) Announces New Details On Its Novel Patient Reported Outcomes (PRO) Tool To Be Used In Phase III HOPE Study     12/6/2016
Gamida Cell Presents Positive Data From Phase 1/2 Study Of NiCord as A Curative Treatment For Sickle Cell Disease At American Society of Hematology 2016     12/6/2016
Novartis AG (NVS) SEG101 (Crizanlizumab, formerly SelG1) Significantly Reduces Frequency Of Sickle Cell Pain Crises In Phase II Study     12/5/2016
Global Blood Therapeutics (GBT) Announces New Long-Term Clinical Data From Ongoing Phase I/II Trial Of GBT440 In Sickle Cell Disease At American Society of Hematology     12/5/2016
Acetylon Presents Preclinical Data Demonstrating The Utility Of Selective HDAC1,2 Inhibition By ACY-957 To Induce Gamma Globin (HBG) Protein Expression For The Treatment Of Sickle Cell Disease And Beta-Thalassemia     12/5/2016
Imara Presents Results For IMR-687, A PDE9 Inhibitor, In Sickle Cell Disease At American Society of Hematology     12/5/2016
American Society of Hematology Release: Sickle Cell Disease Research Shows Progress In Preventing Related Complications And Death     12/5/2016
Calimmune Expands Lentiviral Gene Therapy Pipeline Through License Of Sickle Cell Disease Therapeutic Candidate     12/5/2016
Global Blood Therapeutics (GBT) Announces GBT440 Granted Orphan Drug Designation In Europe For Treatment Of Sickle Cell Disease     12/1/2016
Global Blood Therapeutics (GBT) Announces Upcoming Investor Webcast To Review GBT440 Data Being Presented At American Society of Hematology That Support Sickle Cell Disease Program     12/1/2016
Emmaus Life Sciences Receives Notice Of FDA PDUFA Date For Investigational L-Glutamine Treatment For Sickle Cell Disease     11/29/2016
Bay Area's Global Blood Therapeutics (GBT) and the FDA Finally Reach Agreement on Trial Design for Sickle Cell Disease Drug     10/25/2016
Global Blood Therapeutics (GBT) Presents GBT440 Data That Continue To Support Durability, Safety And Mechanism Of Action In Sickle Cell Disease     10/7/2016
Emmaus Life Sciences Submits New Drug Application For Sickle Cell Disease Treatment     9/8/2016
Emmaus Life Sciences to Seek Marketing Approval for First New Sickle Cell Disease Treatment in Nearly 20 Years; Expects to Submit New Drug Application to FDA in September     8/22/2016

//-->